ClinicalTrials.gg
RecruitingNCT07130084VRECUpdated Aug 19, 2025

Virtual Reality in Elective Caesarean Births Study (VREC)

An interventional study of Virtual Reality Educational Film in Anxiety, Pregnancy and Pain, sponsored by Royal United Hospitals Bath NHS Foundation Trust. Recruiting at 1 site in United Kingdom. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-08-19.

Primary conditionPainRegistry: Anxiety DisordersReclassifiedWhy we changed it
Registry
Anxiety Disorders — the first condition term the registry derived for this study.
ClinicalTrials.gg
Pain
Why
  1. The registry often attaches Anxiety Disorders to studies about something else, and this study's title and listed conditions do not name it.
  2. The study's listed conditions name Pain.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Royal United Hospitals Bath NHS Foundation Trust · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Primary completion was expected by Sep 2025, 1 year 2 months ago, but the record still lists the study as recruiting.
  • Registered 9 months after the study started (first participant enrolled Oct 2024, registered Aug 2025).
  • Started Oct 2024; still recruiting 2 years 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 258 studies in Pain with a site in United Kingdom — 18 open to participants now, 19 under way, 1 of them phase 3. Pain · United Kingdom.

Planned enrollment
156th of 214
40 · median 78
Started
2024
with 11 others
No phase
70 of 258
9 open now
Primary completion
2025-09
later than 5 of 18 live
Registered
249th of 258
by date

Among the 258 studies in Pain with a site in United Kingdom, this one is the 156th largest by planned enrollment of the 214 interventional ones that give a count, is one of 12 that started in 2024, is one of 70 with no phase, reaches primary completion later than 5 of the 18 other live ones, and was the 249th registered.

Pain

10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.

Browse Pain studies →

Open to participants now

18 of the 258 studies in Pain with a site in United Kingdom are open now. Recruiting first, the newest first:

12 more — sign in →

All 18 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.

This study: 18 Years and older · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 258 studies in Pain with a site in United Kingdom, or all of them as a file.
02

Study summary

This study will establish the safety of a known intervention in a novel setting. It will assess how maternal anxiety during the peri-operative period of an elective cesarean section (eCS) is affected by the introduction of a virtual reality (VR) tool. A cesarean section is the most common operation performed in the world. Indeed, locally, we perform approximately 450 eCS annually, equating to 10% of all births. High maternal anxiety in the peri-operative period is well recognised. Although anxiety is considered to be an emotional response it has many physiological consequences which can confer significant morbidity. These include an increased pain perception (with higher analgesic requirement), increased length of hospital stay and a higher risk of infection. Providing high-quality pre-operative information to help patients reduce their anxiety has been used in other medical fields. The use of VR to deliver this information to paediatric populations has been shown to be particularly effective. VR has had limited scope outside of this population and we wish to change this.

Women booked for an eCS at the Royal United Hospital (RUH) will be eligible to participate. A bespoke VR tool (a video of a woman's journey through the process of an elective section at the RUH) will be shown to one group of women prior to eCS whilst another group will receive the standard preoperative information.

A series of quantitative and qualitative data points will be collected across both groups assessing their anxiety and satisfaction with the birthing process throughout the peri-operative period. The two groups will then be compared.

Recruitment will occur prior to the birth during scheduled appointments with the Midwifery team. If proven to be a safe intervention, we hope to run a larger study aiming to determine the efficacy and role of VR in improving maternal outcomes in cesarean births.

Read the detailed description

The Royal College of Obstetrics and Gynaecology (RCOG) has a well-defined framework for involving pregnant women in research studies (clinical governance document 6a). They promote research in obstetrics but stress the key is that research should be completed 'with women, not on women'. For each step of the study, the RCOG framework will be adhered to.

Overview of the study and why it is important

An elective caesarean section (eCS) can be a very anxiety inducing time. Prior to the research project commencing, we developed a questionnaire that all women at Royal United Hospital, Bath (RUH) completed prior to their eCS. This demonstrated consistently high anxiety levels across obstetric populations, including those who had previous emergency caesarean sections. The main source of anxiety was often a fear 'of the unknown' and not knowing what to expect.

Although anxiety is considered to be an emotional response it has many physiological consequences which can confer significant morbidity. These include an increased pain perception (with higher analgesic requirement), increased length of hospital stay and a higher risk of post-operative wound infection.

The purpose of this study is to assess the safety of a virtual reality education film (VREF). The VR will provide a 360degree, 3-dimensional virtual tour demonstrating what will happen on their day of delivery, from entering Bath Birthing Centre through to being on the postnatal ward with their new baby. They will be able to watch this, if they choose, using a head set to make the experience more realistic. The ultimate purpose of the film is to reduce that fear of the unknown by giving patients and their families a detailed view of their upcoming journey.

Given the prevalence of high maternal anxiety and the potential emotional and physical costs of anxiety, it is important to try and develop new interventions to reduce this. However, the safety of any potential intervention is paramount. This study will assess the safety of our VREF.

Step 1: Creating the virtual reality video and writing the script RCOG states that service users should be involved in the development and delivery of the trial. We have already addressed this by involving patients via our PPI (patient and pubic involvement) where we have discussed with the women what they would like to see in the video, when and how they would like to view the video and how they would like the video to help them. We have incorporated all of this information into the script for our virtual reality education film (VREF). The script has been reviewed by multiple health professionals including midwives, obstetricians and anaesthetists to ensure a balanced and accurate view of an eCS is provided. It has also been read by patients prior to their eCS and their feedback has been taken into account for the final version of the script.

We have also discussed how the women feel about the VR element. The VR has been well received, with the main feedback being how useful it will be to be able to 'scroll' around the theatre/wards to fully orientate themselves prior to their eCS.

Step 2: Recruitment to study Potential participants will be identified and given information (patient information leaflet) about the study on an ad hoc basis when booked for their elective LSCS at any point during their pregnancy (as long as it's prior to 38 weeks gestation); this can be done by either their obstetrician or the research midwives.

Approved posters will be on the walls of the antenatal clinic with information about the study and contact details.

Research midwives will then contact the patients by phone to invite them for a formal appointment to consent at 38 weeks. Many patients will be attending hospital at around 38-39 weeks for obstetric follow up, so if feasible, research appointments will be aligned with this. If patients are not attending routinely, we will invite them for an appointment with the research midwives at an alternative time.

Formal consent will be sought at the appointment. Given that this study will only be undertaken for elective procedures, all patients will have plenty of time to weigh up the information provided to them before consenting to research and will be able to withdraw from the study any time.

RCOG states the importance of providing the service user with multiple ways to access information about the trial. Is also advises that any information leaflets should be produced in conjunction with the service user to ensure that they are easy to understand as well as accurate. The women will have access to both.

Step 3: Randomisation and baseline anxiety scores and cortisol levels Randomisation will be performed by a computer on a 1:1 basis to eliminate any bias. Patients that are randomised to the control arm will not have their care disadvantaged in any way. They will receive all the standard antenatal care and normal information that we provide prior to an eCS.

All women who consent to the study will require baseline scores for

  • State Trait Anxiety Inventory Scale-5
  • Visual Analogue Scale for Anxiety
  • Serum Cortisol These will be carried out at the 38-39 week routine appointment at DAU to again reduce any additional trips to the hospital. The two anxiety scales/indexes are well validated having been used extensively in research projects across many populations and there are no ethical concerns regarding these.

A blood sample will need to taken for serum cortisol. The women always have a blood sample taken at this appointment to obtain a valid 'Group\& Save' and Full Blood Count prior to surgery so there will be no additional venepuncture. All venepuncture and handling of blood products will be carried out by trained personnel in accordance with the Trust's guidelines and policies. For patients randomised to the intervention arm, they will be shown this video during their visit to DAU (Day Assessment Unit). As per the RCOG framework, the welfare of the woman and baby will take priority over any research, and the patients can stop watching the film at any time if they wish to do so.

After watching the VREF they will be able to ask the midwifery team any questions they might have. They will also be given access so they can watch the VREF on their own devices at home if they wish. The women in the intervention arm will also be provided with all the standard antenatal care and information to ensure they are not disadvantaged in any way.

Step 4: Day of elective caesarean section During the day of the eCS, the health and welfare of the woman and baby will be the absolute priority. We will ensure the women understand that they can withdraw from the study at any time during the day or in the recovery period and that this will not affect their care or treatment in any way.

During the day, there will be three time points at which we ask the patients to complete the following; On admission

  • State Trait Anxiety Inventory Scale 5
  • Visual Analogue Scale for Anxiety
  • Serum Cortisol At skin closure
  • State Trait Anxiety Inventory Scale 5
  • Visual Analogue Scale for Anxiety
  • Serum Cortisol 2 hours post-LSCS
  • State Trait Anxiety Inventory Scale 5
  • Visual Analogue Scale for Anxiety
  • Serum Cortisol
  • Patient satisfaction score
  • Visual Analogue Scores for pain The serum cortisol level (blood test) will need to be taken at all three time points. Wherever possible this will be coordinated with the need for routine venepuncture/cannulation to reduce unnecessary venepuncture. Again, these samples will be taken by appropriately trained professionals to minimise the risk of repeated attempts.

Further information surrounding the birth such as time of birth, time of anaesthesia and fetal APGAR's will be collected unobtrusively by the anaesthetist to give the woman time to bond with her baby once delivered.

Step 5: Day after elective caesarean section

All women will remain an inpatient for at least 24 hours following a caesarean section so we will not need to women to re-attend hospital to gather any follow up data. The following data will be collected:

  • Patient satisfaction score
  • State Trait Anxiety Inventory Scale 5
  • Visual Analogue Scale for Anxiety
  • Visual Analogue Scores for pain
  • Analgesia consumption in first 24 hours post-LSCS
  • Time to breastfeed post-LSCS
  • Time to mobilise post-LSCS This data will only be collected if the woman is happy to answer the questions, and we will ensure it is a convenient time for the mother to answer these questions. Again, keeping the welfare of the mother and baby at the forefront.

The following data will be collected from the patient's notes or anaesthetic chart (a sticker will be attached to the anaesthetic chart for the anaesthetist to complete):

  • Time of anaesthesia
  • Time of adequate block
  • Time of birth
  • Time of closing of the skin
  • Did the mother have skin-to-skin with baby? What time?
  • Fetal 5-minute APGAR
  • Any unexpected events

Use of Virtual Reality in research

A brief literature review demonstrates there are at least 890 studies assessing virtual reality and anxiety. Virtual reality has been proven to be safe and accepted across multiple populations, including the paediatric population. A VR video was developed by J-H Ryu et al. for paediatric patients about to undergo an elective operation. The video gives them a tour of the operating suite prior to surgery. They report that it was well accepted by patients and their carers' and also demonstrated a reduction in pre-operative anxiety.

There is more limited use of VR in the obstetric population, but studies do exist. For example, Frey et al used VR during labour to assess its use as an analgesic. They again found VR to be an acceptable intervention and found it reduced both perceived pain and anxiety during labour.

In 'Health and safety implications of virtual reality: a review of empirical evidence' , Sharples and Patel discuss some of the potential health and safety implications. The main area they identify if the potential for nausea if fully immersive headsets are used. In our study, the use of headsets are fully optional, and women can stop using a headset at any time if it was causing any nausea.

Overall, virtual reality is a safe and well accepted intervention across multiple populations. We will carefully monitor for any adverse effects and stop the trial immediately if there were any concerns.

Inclusion/Exclusion Criteria:

Patients undergoing elective lower segment caesarean section (LSCS) at the Royal United Hospital, Bath.

Eligibility:

  • Have had the decision for elective LSCS by 38 weeks gestation.
  • Has never had an emergency or elective section previously
  • Have a procedure planned and performed as a category 4 LSCS (an elective LSCS booked at a time that suits both the woman and obstetric team)
  • Have use of an android or iOS operating system smartphone or tablet device.
  • Have access to the internet.
  • Have an active email address.
  • Have capacity to consent to participate in the study.

Exclusion criteria:- Patient \<18 years of age.- Patient refusal.- Women more likely to have atypical anxiety-related behaviour, restricted to:- Patients with a current severe mental health disorder under the care of the perinatal mental health team- Patients with medical or obstetric co-morbidities requiring pre-determined admission to maternity HDU care

  • Congenital structural abnormalities requiring pre-determined admission to NICU- Patients where spinal anaesthesia is contra-indicated.- Patients who do not have access to a smart phone/computer

Withdrawal criteria

  • Emergency LSCS - those in the following standardised categories of urgency as set out by NICE[23].

    • Category 1 - immediate threat to life of woman or fetus
    • Category 2 - maternal or fetal compromise which is not immediately life-threatening
    • Category 3 - no maternal or fetal compromise but needs early birth
  • Women who receive a general anaesthetic.

Information Governance:

As per the RCOG guidelines, patient confidentiality will be maintained at all time. All data will be entered into a Trust based computer that is password protected. Subject names will be kept on a database and will be linked only with a study identification number for this research. There will be no patient identifiers. Only the research team will have access to this computer. Personal data will be stored in a locked office and maintained for 12 months after the completion of the study. Research data generated by the study will be stored for 5 years. Data will be collected and retained in accordance with the Data Protection Act 1998.

03

Conditions studied

  • Anxiety
  • Pregnancy
  • Pain

Browse trials for

Keywords

  • Virtual reality
04

In context

Pain Reclassified

10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.

This study's planned enrollment of 40 is below the median of 66 across 8,512 interventional studies indexed under Pain.

Browse Pain studies →

Lead sponsor

Royal United Hospitals Bath NHS Foundation Trust is the lead sponsor of 19 studies on the registry; 7 are open to participants now.

Compared within Pain, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Anxiety Disorders. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Have had the decision for elective LSCS by 38 weeks gestation.
  • Has never had an emergency or elective section previously
  • Have a procedure planned and performed as a category 4 LSCS (an elective LSCS booked at a time that suits both the woman and obstetric team)
  • Have use of an android or iOS operating system smartphone or tablet device.
  • Have access to the internet.
  • Have an active email address.
  • Have capacity to consent to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • Patient \<18 years of age
  • Patient refusal
  • Patients who have had an emergency or elective LSCS previously.
  • Patients with a history of anxiety disorders
  • Patients with medical or obstetric co-morbidities requiring pre-determined admission to maternity HDU care
  • Congenital structural abnormalities requiring pre-determined admission to NICU
  • Patients where spinal anaesthesia is
  • Women who have English of an insufficient standard to comprehend the consent and assessment process
  • Prisoners
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

06

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Virtual reality educational film

    The intervention arm will receive the standard antenatal care and pre-operative education plus will view the Virtual Reality Educational Film

    Other: Virtual Reality Educational Film

  • No intervention
    Control arm

    The control arm will receive all standard antenatal care and pre-operative education

Interventions

  • OtherVirtual Reality Educational Film

    The Virtual Reality Educational Film will be viewed during the antenatal appointment, post randomisation. The women will have access to the film at home should they want to watch it more than once.

07

What researchers measure

Primary outcomes

  1. patient feedback questionnaire after watching virtual reality education film

    Patients will complete a feedback questionnaire to assess if a pre-operative virtual reality education film is safe, feasible and acceptable intervention in women who have had an elective Cesarean section.

    Time frame: from enrollment up to 1 weeks post cesarean section

Secondary outcomes

  1. State Trait Anxiety Inventory Scale 5

    The State-Trait Anxiety Inventory (STAI) is a commonly used measure of anxiety. It has 5 items for assessing anxiety. Each item is self rated on a score or 1-4 (1= not at all; 4=very much so). Item statements are: 'I feel upset', 'I feel frightened', 'I feel nervous', 'I feel jittery', and 'I feel confused'. STAI is completed at 5 time points (T1 at pre-clerking (approximately 38-39 weeks gestation), T2 on admission for LSCS, T3 at skin closure, T4 2 hour's post-LSCS, T5 at 24 hours post-LSCS patient will be phoned if they have left the hospital).

    Time frame: from enrollment up to 48 hours post cesarean section

  2. Visual Analogue Scale for Anxiety

    VAS-A is a validated, self-reported instrument assessing anxiety. Participants are asked to indicate their level of anxiety on a scale from 0-10 (number 0 indicates no anxiety and the number 10 indicates severe anxiety) VAS-A at 5 time points (T1 at pre-clerking approximately 38-39 weeks gestation, T2 on admission for LSCS, T3 at skin closure, T4 2 hours post-LSCS, T5 at 24 hours post-LSCS patient will be phoned if they have left the hospital ) (Score 0-10).

    Time frame: from enrollment up to 48 hours post delivery

  3. Serum cortisol

    Cortisol is a hormone and levels can alter depending on the stress response. It requires a blood test and will be measured at 4 time points (T1 at pre-clerking at approximately 38-39 weeks gestation, T2 on admission for LSCS, T3 at skin closure, T4 at 2 hours post-LSCS)

    Time frame: From enrollment up to 48 hours post delivery

  4. Patient satisfaction scores

    Participants are asked to rate their satisfaction on the care they received on a scale 0 -10, where 0 is very poor and 10 is extremely satisfied. Scores at two time points (T4 at 2 hours post-LSCS and T5 at 24 hours post-LSCS, patient will be phoned if they have left the hospital)(Score 0-10)

    Time frame: enrollment up to 48 hours post cesarean section

  5. Visual Analogue Scores (VAS) for pain

    VAS-P is a validated, self-reported instrument for assessing pain in the peri-operative period. Participants are asked to select a point on the scale indicating the level of pain they are feeling. The number 0 indicates no pain and the number 10 indicates the worse pain possible This is performed at two time points (T4 at 2 hours post-LSCS, T5 at 24 hours post-LSCS patient will be phoned if they have left the hospital) (Score 0 to 10)

    Time frame: up to 48 hours post cesarean section

  6. Analgesia consumption

    Analgesia consumption in first 24 hours post-LSCS (amount of morphine in mg)

    Time frame: from delivery up to 48hours post delivery

08

Study locations

1 of 1 sites recruiting
  • Bath Birthing Centre, Royal United Hospital Bath Foundation Trust
    Bath, BA1 3NG, United Kingdom
    Recruiting
    • Rebecca Leslie, MB BS, BMed Sci, FRCA, PGDip · Contactrebecca.leslie1@nhs.net · +44 1225 825057
    • Amy Lloyd, R&D officer · Contactamylloyd@nhs.net · +44 1225 825738
    • Rebecca Leslie, MB BS, BMed Sci, FRCA, PGDip · Principal investigator
09

References and documents

Publications

  • Zsido AN, Teleki SA, Csokasi K, Rozsa S, Bandi SA. Development of the short version of the spielberger state-trait anxiety inventory. Psychiatry Res. 2020 Sep;291:113223. doi: 10.1016/j.psychres.2020.113223. Epub 2020 Jun 12. PubMed 32563747 ↗
  • Kindler CH, Harms C, Amsler F, Ihde-Scholl T, Scheidegger D. The visual analog scale allows effective measurement of preoperative anxiety and detection of patients' anesthetic concerns. Anesth Analg. 2000 Mar;90(3):706-12. doi: 10.1097/00000539-200003000-00036. PubMed 10702461 ↗
  • Mackenzie JW. Daycase anaesthesia and anxiety. A study of anxiety profiles amongst patients attending a day bed unit. Anaesthesia. 1989 May;44(5):437-40. doi: 10.1111/j.1365-2044.1989.tb11349.x. PubMed 2787129 ↗
  • Jiang L, Zhang K, He W, Zhu X, Zhou P, Lu Y. Perceived Pain during Cataract Surgery with Topical Anesthesia: A Comparison between First-Eye and Second-Eye Surgery. J Ophthalmol. 2015;2015:383456. doi: 10.1155/2015/383456. Epub 2015 May 4. PubMed 26064671 ↗
  • North MM, North SM. Virtual reality therapy. In: Computer-assisted and web- based innovations in psychology, special education, and health. London: lsevier; 2016. p. 141-56.
  • Dehghan F, Jalali R, Bashiri H. The effect of virtual reality technology on preoperative anxiety in children: a Solomon four-group randomized clinical trial. Perioper Med (Lond). 2019 Jun 4;8:5. doi: 10.1186/s13741-019-0116-0. eCollection 2019. PubMed 31171963 ↗
  • Sjoling M, Nordahl G, Olofsson N, Asplund K. The impact of preoperative information on state anxiety, postoperative pain and satisfaction with pain management. Patient Educ Couns. 2003 Oct;51(2):169-76. doi: 10.1016/s0738-3991(02)00191-x. PubMed 14572947 ↗
  • Gammon J, Mulholland CW. Effect of preparatory information prior to elective total hip replacement on psychological coping outcomes. J Adv Nurs. 1996 Aug;24(2):303-8. doi: 10.1046/j.1365-2648.1996.17911.x. PubMed 8858434 ↗
  • Johnston M, Vogele C. Benefits of psychological preparations for surgery: a meta-analysis. Annuals of Behavioural Medicine. 1993; 15: 245-56.
  • Devine EC. Effects of psychoeducational care for adult surgical patients: a meta-analysis of 191 studies. Patient Educ Couns. 1992 Apr;19(2):129-42. doi: 10.1016/0738-3991(92)90193-m. PubMed 1299818 ↗
  • Hobson JA, Slade P, Wrench IJ, Power L. Preoperative anxiety and postoperative satisfaction in women undergoing elective caesarean section. Int J Obstet Anesth. 2006 Jan;15(1):18-23. doi: 10.1016/j.ijoa.2005.05.008. Epub 2005 Oct 26. PubMed 16256338 ↗
  • Gorkem U, Togrul C, Sahiner Y, Yazla E, Gungor T. Preoperative anxiety may increase postcesarean delivery pain and analgesic consumption. Minerva Anestesiol. 2016 Sep;82(9):974-80. Epub 2016 Mar 30. PubMed 27028449 ↗
  • Schupp CJ, Berbaum K, Berbaum M, Lang EV. Pain and anxiety during interventional radiologic procedures: effect of patients' state anxiety at baseline and modulation by nonpharmacologic analgesia adjuncts. J Vasc Interv Radiol. 2005 Dec;16(12):1585-92. doi: 10.1097/01.RVI.0000185418.82287.72. PubMed 16371522 ↗
  • Chieng YJ, Chan WC, Klainin-Yobas P, He HG. Perioperative anxiety and postoperative pain in children and adolescents undergoing elective surgical procedures: a quantitative systematic review. J Adv Nurs. 2014 Feb;70(2):243-55. doi: 10.1111/jan.12205. Epub 2013 Jul 19. PubMed 23865442 ↗
  • Carr E, Brockbank K, Allen S, Strike P. Patterns and frequency of anxiety in women undergoing gynaecological surgery. J Clin Nurs. 2006 Mar;15(3):341-52. doi: 10.1111/j.1365-2702.2006.01285.x. PubMed 16466484 ↗
  • Pokharel K, Bhattarai B, Tripathi M, Khatiwada S, Subedi A. Nepalese patients' anxiety and concerns before surgery. J Clin Anesth. 2011 Aug;23(5):372-8. doi: 10.1016/j.jclinane.2010.12.011. PubMed 21802628 ↗
  • Navarro-Garcia MA, Marin-Fernandez B, de Carlos-Alegre V, Martinez-Oroz A, Martorell-Gurucharri A, Ordonez-Ortigosa E, Prieto-Guembe P, Sorbet-Amostegui MR, Indurain-Fernandez S, Elizondo-Sotro A, Irigoyen-Aristorena MI, Garcia-Aizpun Y. [Preoperative mood disorders in patients undergoing cardiac surgery: risk factors and postoperative morbidity in the intensive care unit]. Rev Esp Cardiol. 2011 Nov;64(11):1005-10. doi: 10.1016/j.recesp.2011.06.009. Epub 2011 Sep 15. Spanish. PubMed 21924811 ↗
  • Caumo W, Ferreira MB. Perioperative anxiety: Psychobiology and effects in postoperative recovery. Pain Clin 2003;15:87 101.
  • Hepp P, Hagenbeck C, Burghardt B, Jaeger B, Wolf OT, Fehm T, Schaal NK; MAGIC Group. Measuring the course of anxiety in women giving birth by caesarean section: a prospective study. BMC Pregnancy Childbirth. 2016 May 18;16:113. doi: 10.1186/s12884-016-0906-z. PubMed 27188222 ↗
  • Wyatt SS, Jones DA, Peach MJ, Gurrin L. Anxiety in patients having caesarean section under regional anaesthesia: a questionnaire and pilot study. Int J Obstet Anesth. 2001 Oct;10(4):278-83. doi: 10.1054/ijoa.2001.0866. PubMed 15321585 ↗
  • Speilberger CD Gorsuch RL, Lushene RE, Vagg P & Jacobs G. 1983. State-trait Anxiety Inventory (STAI). Mind garden, Menlo Park, CA.

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — Individual participant data will not be shared. Only aggregated, anonymised results will be published.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2024 (actual). Primary completion is estimated for Sep 2025, 10 months after the start.

Of 3,749 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's planned 10 months is close to that.

Counting every sponsor, half of 3,848 studies reached it within 10 months; a quarter within 4 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 12, 2025
First posted
Aug 19, 2025
StartActual
Oct 14, 2024
Primary completionEst.
Sep 1, 2025
CompletionEst.
Sep 1, 2025
Last update
Aug 19, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 19, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT07130084
Lead sponsor
Royal United Hospitals Bath NHS Foundation Trust
Responsible party
Rebecca Leslie (Consultant in Anaesthesia, Royal United Hospitals Bath NHS Foundation Trust) — Principal investigator
First posted
Aug 19, 2025
Start date
Oct 14, 2024
Primary completion
Sep 1, 2025 (estimated)
Completion
Sep 1, 2025 (estimated)
Last update
Aug 19, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion